Philips Reports Strong 2025 Financial Results and Strategic Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy PHG?
Source: Newsfilter
- Significant Order Growth: In 2025, comparable order intake grew by 6%, with a 7% increase in Q4, indicating Philips' successful customer attraction in a dynamic market environment, enhancing future revenue sustainability.
- Sales and Profit Improvement: Group sales reached EUR 17.8 billion in 2025, with EUR 5.1 billion in Q4, while the adjusted EBITA margin increased by 80 basis points to 12.3% in 2025, demonstrating the company's effectiveness in cost control and innovation.
- Strong Cash Flow Performance: Free cash flow amounted to EUR 512 million in 2025, reaching EUR 1.2 billion in Q4, reflecting Philips' ongoing improvements in operational efficiency and financial health, providing ample funding for future investments.
- Strategic Development Plan: Philips outlined its financial targets for 2026-2028, expecting mid-single-digit comparable sales growth CAGR of 3%-4.5% and aiming for a mid-teens adjusted EBITA margin by 2028, showcasing the company's confidence and strategic direction for future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHG
About PHG
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement Date: Philips is set to release its Q4 earnings on February 10 before the market opens, with consensus EPS estimated at $0.50, reflecting a 2% year-over-year decline, while revenue is projected at $5.83 billion, indicating a robust 15.7% year-over-year growth, showcasing the company's strong revenue performance.
- Historical Performance: Over the past two years, Philips has exceeded EPS and revenue estimates 100% of the time, indicating stability in financial forecasting and market performance, which enhances investor confidence.
- Estimate Revision Dynamics: In the last three months, Philips has seen one upward revision and no downward adjustments in EPS estimates, while revenue estimates experienced one upward and two downward revisions, reflecting mixed market sentiments regarding the company's future performance that could influence investor decisions.
- Macro Environment and AI Tailwinds: Philips' leadership in healthcare AI, combined with favorable macro conditions, may present additional growth opportunities for the company, further solidifying its competitive advantage in the industry.
See More
- Philips Strong Performance: Koninklijke Philips NV reported upbeat fourth-quarter results, with shares rising 0.5% to close at $29.62, indicating the company's stable market performance and boosting investor confidence.
- Ford Earnings Expectations: Analysts anticipate Ford Motor Co. will report quarterly earnings of 19 cents per share on revenue of $41.83 billion after the market close, increasing investor focus on its financial performance, which may impact stock price movements.
- Market Dynamics: U.S. stock futures are trading slightly lower this morning, reflecting investor caution ahead of upcoming earnings reports, which could lead to increased market volatility.
- Investor Focus: As the earnings reports for Philips and Ford approach, investors are keenly watching these companies' performances to assess overall market trends and the health of the industry.
See More
- Q4 Performance: Philips reported a Q4 non-GAAP EPS of EUR 0.60 with revenues of EUR 5.1 billion, indicating stable performance in the healthcare sector despite market challenges.
- Future Growth Expectations: The company anticipates comparable sales growth of 3% to 4.5% for 2026, with an adjusted EBITA margin projected at 12.5% to 13.0%, reflecting Philips' proactive strategy to enhance profitability and market share.
- Dividend Proposal: Philips proposed a 2025 dividend of EUR 0.85 per share, available in cash or stock at the shareholder's option, aimed at increasing shareholder returns and attracting long-term investors.
- Mid-term Targets: The company has set mid-term goals for 2026-2028, including mid-single-digit CAGR for comparable sales, mid-teens adjusted EBITA margin, and a cumulative free cash flow of EUR 4.5 to 5.0 billion, demonstrating confidence in its future financial health.
See More
- Profit Reversal: Philips reported a net income of €397 million in Q4, a significant turnaround from a loss of €333 million last year, indicating a recovery in profitability driven by sales growth, which boosts investor confidence.
- Earnings Per Share Growth: The earnings per share improved from a loss of €0.35 to €0.41, while adjusted income from continuing operations rose from €0.50 to €0.60 per share, reflecting a sustained improvement in the company's profitability.
- Sales and Order Growth: Q4 sales increased by 1% to €5.097 billion, with comparable sales growth of 7%, demonstrating strong performance across all business segments, particularly in the North American market.
- Future Outlook: Philips anticipates an adjusted EBITA margin of 12.5% to 13.0% for 2026 and plans to propose a dividend of €0.85 per share at the 2026 Annual General Meeting, showcasing confidence in future profitability.
See More
- Significant Order Growth: In 2025, comparable order intake grew by 6%, with a 7% increase in Q4, indicating Philips' successful customer attraction in a dynamic market environment, enhancing future revenue sustainability.
- Sales and Profit Improvement: Group sales reached EUR 17.8 billion in 2025, with EUR 5.1 billion in Q4, while the adjusted EBITA margin increased by 80 basis points to 12.3% in 2025, demonstrating the company's effectiveness in cost control and innovation.
- Strong Cash Flow Performance: Free cash flow amounted to EUR 512 million in 2025, reaching EUR 1.2 billion in Q4, reflecting Philips' ongoing improvements in operational efficiency and financial health, providing ample funding for future investments.
- Strategic Development Plan: Philips outlined its financial targets for 2026-2028, expecting mid-single-digit comparable sales growth CAGR of 3%-4.5% and aiming for a mid-teens adjusted EBITA margin by 2028, showcasing the company's confidence and strategic direction for future growth.
See More
- Leadership Recognition: Royal Philips has nominated Roy Jakobs for reappointment as CEO, reflecting the Supervisory Board's acknowledgment of the progress made since 2022 and confidence in his leadership amid an uncertain macro environment.
- Financial Resilience Improvement: Under Jakobs' leadership, the company achieved EUR 2.5 billion in productivity savings, enhancing financial resilience while simplifying organizational structure and improving execution, resulting in restored growth and increased margins.
- Cultural Transformation: Jakobs has focused on improving patient safety and quality culture, driving the team to prioritize innovation and performance, ensuring the company's sustained competitiveness in the health technology sector.
- Future Growth Plans: Jakobs will present Philips' plan for profitable growth at the Capital Markets Day, aimed at creating long-term sustainable value for all stakeholders and further solidifying the company's market position.
See More








